Search - tctmd.com

Displaying 541 - 560 of 892

Sort: Relevancy | Date

News Daily News

Hospital Readmissions at 30 Days Declining for Stroke Patients

Michael O'Riordan

August 20, 2018

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

News Daily News

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

Lucy Hicks

July 30, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

News Daily News

ICD Use Curbed at Hospitals After US Department of Justice Scrutiny

Caitlin E. Cox

July 05, 2018

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Todd Neale

July 02, 2018

News Daily News

CVD Prevention and Control Remains a Challenge in India

L.A. McKeown

June 26, 2018

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

News Daily News

Oral Anticoagulation Boosts Poststroke Outcomes in Patients With A-fib

Todd Neale

May 18, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

L.A. McKeown

May 16, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

News Daily News

Remaining Active After MI May Help Stave Off Mortality

Todd Neale

April 23, 2018

News Daily News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Michael O'Riordan

April 20, 2018

News Daily News

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

L.A. McKeown

April 19, 2018

Advertisement

Hospital Readmissions at 30 Days Declining for Stroke Patients

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

ICD Use Curbed at Hospitals After US Department of Justice Scrutiny

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

CVD Prevention and Control Remains a Challenge in India

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Oral Anticoagulation Boosts Poststroke Outcomes in Patients With A-fib

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

LPA Variants Linked With CHD Events in Statin-Treated Patients

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

Remaining Active After MI May Help Stave Off Mortality

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content